Sao Paulo (1)

Acute Lymphoblastic Leukemia Refractory (1)

Acute Lymphoblastic Leukemia, in Relapse (1)

B-cell Lymphoma Recurrent (1)

B-cell Lymphoma Refractory (1)

Chronic Lymphocytic Leukemia Recurrent (1)

Chronic Lymphocytic Leukemia Refractory (1)

Not yet recruiting (1)

phase 1 (1)

Hospital Israelita Albert Einstein (1)

Miltenyi Biotec, Inc. (1)

chimeric antigen receptor t cells to be implemented in a "3 + 3" design on day 0 (1)

cyclophosphamide (1)

fludarabine (1)

biological (1)

drug (1)

Other (1)

Interventional (1)

chronic lymphocytic leukemia refractory

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Jan 20, 2023